Learn as industry experts discuss how companies in the alternative energy space identify, package, and find financing for biofuel, solar, and wind projects in the Western United States. Panelists provide in-depth perspective on the status of federal and state funding as well as how to avoid regulatory hurdles that can trip up an otherwise great alternative energy project.
Moderator:
- S. Wayne Rosenbaum, Partner, Foley & Lardner LLP
Panelists:
- Cheryl Bostater, Principal, Vantage Point Advisors Inc.
- Terrance Bruggeman, Executive Chairman, BioTork, LLC
- Scott L. Klug, Public Affairs Director, Foley & Lardner LLP
- David Saltman, Chairman and Chief Executive Officer, Malama Composites, Inc.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.